,,,acccchhhh,,,,,an attempt at damage control,,,,,nothing new as expected,,,,,,,,no meaningful timelimes from what I read,,,,,,,every milestone worth mentioning is still out there in the abyss of time. Blaming a hedge fund for the blood in the streets around our share price is less than a stellar answer,,,,,,,,,,no other fund or institution out there to transfer the large block or blocks of shares to??,,just sell into the open market for what is most likely a minimum return for the fund,,,,that is some kind of a wind down for sure!,,,,,,no interest from the investing world in RVX potential must be assumed here.  Not even the big pocket insiders stepping up to acquire such shares,,they know they can get them cheaper with additional warrants as they fund the sit and wait,,works to their advantage.

Interest from the biotech investing community in this stock is DMs' job. Sorry, but the buck stops at his door, he is the CEO and chairs the BoD. After years of travelling the world to sell this story and being told we are 8 to 10 years ahead of any competition, with hundreds of molecules in wait, a phase lll under our belt and the best this management team can do is .70 cents CAD!,,good grief Charlie Brown...,,,jmo